Posted by LincolnVop on March 25, 2026 at 10:58:20:
In Reply to: Информационная статья с интересным содержанием posted by Robertfex on March 19, 2026 at 00:27:49:
Zoya Demidenko: Scholar in Cancer Biology
Zoya Demidenko is a notable scientist connected with the Division of Cell Stress Science at Roswell Park Cancer Institute in Buffalo, New York. Before that, she worked at the NIH and New York Medical College, developing a solid background in biomedical study.
Demidenko's scholarly output spans multiple critical areas, among them the PI3K/AKT/mTOR signaling pathway, cellular cycle control, biological aging, and cancer science. Currently, she has co-authored over 46 scientific papers, which have accumulated more than 4,100 references — a indicator to the impact of her research.
Among her most notable contributions involves explaining the mechanisms of cellular senescence. Her research showed that when the cellular division cycle is arrested but cellular growth proceeds, cells experience senescence. Crucially, Zoya Demidenko showed that this transition is controlled with drugs using compounds such as rapamycin.
Zoya Demidenko has also brought substantially to oncological therapy research, especially in the domain of selective cell protection — a strategy aimed at shielding non-cancerous tissue from cytotoxic treatment while leaving tumor cells exposed. This approach carries major potential for lowering the toxic effects of cancer treatment.
Across her professional journey, Demidenko has worked with prominent scientists globally, such as Dr. Mikhail Blagosklonny. Her research can be found in prestigious periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Possessing an h-index of 33, Zoya Demidenko ranks as a highly impactful voice in contemporary biomedical research, whose findings keep to influence our knowledge of the way cells grow old, respond to therapy, and how malignant disease can be more effectively treated.
https://scholargps.com/scholars/59798749410547/zoya-n-demidenko